Early events of metastasis in the microcirculation involve changes in gene expression of cancer cells: Tracking mRNA levels of metastasizing cancer cells in the chick embryo chorioallantoic membrane

American Journal of Pathology

Volumn 150, Issue 6, 1997, Pages 2099-2112

  Shioda, Toshihiro ^a   Munn, Lance L ^b   Fenner, Martin H ^a   Jain, Rakesh K ^b   Isselbacher, Kurt J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER GENETICS; CHICK EMBRYO; CHORIOALLANTOIS; EMBRYO; GENE EXPRESSION; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MICROCIRCULATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ANALYSIS;

ACTINS; ALLANTOIS; ANIMALS; CHICK EMBRYO; CHORION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, FOS; MELANOMA, EXPERIMENTAL; MICE; MICROCIRCULATION; MICROSCOPY, FLUORESCENCE; MICROSCOPY, VIDEO; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TETRADECANOYLPHORBOL ACETATE; TETRAHYDROFOLATE DEHYDROGENASE; TUMOR CELLS, CULTURED;

EID: 0030984920     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Liotta LA, Rao CN, Barsky SH: Tumor invasion and the extracellular matrix. Lab Invest 1983, 49:363
2. Schirrmacher V: Experimental approaches, theoretical concepts, and impacts for treatment strategies. Adv Cancer Res 1985, 43:1-32
3. Fidler U: Origin and biology of cancer metastasis. Cytometry 1989, 10:673-680
4. Fidler U: Critical factors in the biology of human cancer metastasis. Cancer Res 1990, 50:6130-6138
5. Hart IR, Saini A: Biology of tumour metastasis. Lancet 1992, 339:1453-1457
6. 125I-5-iododeoxyuridine. J Natl Cancer Inst 1970, 45:773-782
7. Fidler IJ: Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res 1975, 35:218-224
8. Humphries MJ, Matsumoto K, White SL, Olden K: Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. Cancer Res 1986, 46:5215-5222
9. Humphries MJ, Olden K, Yamada KM: A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986, 233:467-470
10. Hanna N: Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural killer cell-mediated cytotoxicity. Int J Cancer 1980, 26:675-680
11. Zhu D, Cheng C-F, Pauli BU: Blocking of lung endothelial cell adhesion molecule-1 (Lu-ECAM-1) inhibits murine melanoma lung metastasis. J Clin Invest 1992, 89:1718-1724
12. Koop S, Khokha R, Schmidt EE, MacDonald IC, Morris VL, Chambers AF, Groom AC: Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res 1994, 54:4791-4797
13. Koop S, MacDonald IC, Luzzi K, Schmidt EE, Morris VL, Grattan M, Khokha R, Chambers AF, Groom AC: Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate. Cancer Res 1995, 55: 2520-2523
14. Maroney AC, Qureshi SA, Foster DA, Brugge JS: Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells. Oncogene 1992, 7:1207-1214
15. Lichtenfels R, Biddison WE, Schulz H, Vogt AB, Martin R: CARE-LASS (calcein-release-assay), an improved, fluorescence-based test system to measure cytotoxic T cell activity. J Immunol Methods 1994, 172:227-239
16. Nguyen M, Shing Y, Folkman J: Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc Res 1994, 47:31-40
17. Rappolee DA, Mark D, Banda MJ, Webb Z: Wound macrophages express TGF-α and other growth factors in vivo: analysis by mRNA phenotyping. Science 1988, 241:708-712
18. 1 cells: role of protein kinase C activation and on-going transcription. Proc Natl Acad Sci USA 1994, 91:11919-11923
19. Schonthal A, Herrlich P, Rahmsdorf HJ, Ponta H: Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 1988, 54:325-334
20. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336
21. Liotta LA, Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991, 51:5054-5059
22. Matrisian LM: The matrix-degrading metalloproteinases. BioEssays 1992, 14:455-463
23. Hu E, Mueller E, Oliviero S, Papaioannou VE, Johnson R, Spiegelman BM: Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J 1994, 13:3094-3103
24. Gack S, Vallon R, Schaper J, Rüther U, Angel P: Phenotypic alterations in Fos-transgenic mice correlated with changes in Fos/Jun-dependent collagenase type I expression. J Biol Chem 1994, 269:10363-10369
25. Saez E, Rutberg SE, Mueller E, Oppenheim H, Smoluk J, Yuspa SH, Spiegelman BM: c-fos is required for malignant progression of skin tumors. Cell 1995, 82: 721-732
26. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N: Regulation of vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 1995, 95: 1789-1797
27. Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo K-T, Manseau EJ, Dvorak HF: Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 1996, 56:172-181
28. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995, 146:1029-1039
29. Mukhopadhyay D, Tsiokas L, Zhou X-M, Foster D, Brugge JS, Sukhatme VP: Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 1995, 375:577-581
30. Stein I, Neeman M, Shweiki D, Itin A, Keshet E: Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 1995, 15:5363-5368
31. Levy AP, Levy NS, Wegners S, Goldberg MA: Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995, 270:13333-13340
32. Frank S, Hübner G, Breier G, Longaker MT, Greenhalgh DG, Werner S: Regulation of vascular endothelial growth factor expression in cultured keratinocytes: implications for normal and impaired wound healing. J Biol Chem 1995, 270:12607-12613
33. Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD: Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: synergistic interaction with hypoxia. Circulation 1995, 92:11-14
34. Grugel S, Finkenzeller G, Weindel K, Barleon B, Marmé D: Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J Biol Chem 1995, 270:25915-25919
35. Karnofsky DA, Ridgway LP, Patterson PA: Tumor transplantation to the chick embryo. Ann NY Acad Sci 1952, 55:313-329
36. Chambers AF, Shafir R, Ling V: A model system for studying metastasis using the embryonic chick. Cancer Res 1982, 42:4018-4025
37. Ossowski L, Reich E: Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 1983, 35: 611-619
38. Chambers AF, Ling V: Selection for experimental metastatic ability of heterologous tumor cells in chick embryo after DMA-mediated transfer, Cancer Res 1984, 44:3970-3975
39. Chambers AF, Wilson SM, Tuck AB, Denhardt GH, Cairncross JG: Comparison of metastatic properties of a variety of mouse, rat, and human cells in assays in nude mice and chick embryos. In Vivo 1990, 4:215-220
40. Chambers AF, Schmidt EE, MacDonald IC, Morris VL, Groom AC: Early steps in hematogenous metastasis of B16F1 melanoma cells in chick embryo studied by high-resolution intravital videomicroscopy. J Natl Cancer Inst 1992, 84:797-803
41. Khoka R, Zimmer MJ, Wilson SM, Chambers AF: Upregulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin Exp Metastasis 1992, 10:365-370
42. Brooks PC, Lin J-M, French DL, Quigley JP: Subtractive immunization yields monoclonal antibodies that specifically inhibit metastasis. J Cell Biol 1993, 122:1351-1359
43. Tsuchiya Y, Sato H, Endo Y, Okada Y, Mai M, Sasaki T, Seiki M: Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo. Cancer Res 1993, 53:1397-1402
44. Khokha R: Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst 1994, 86:299-304
45. Kook YH, Adamski J, Zelent A, Ossowski L: The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy. EMBO J 1994, 13:3983-3991
46. Koop S, Schmidt EE, MacDonald IC, Morris VL, Khokha R, Grattan M, Leone J, Chambers AF, Groom AC: Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well. Proc Natl Acad Sci USA 1996, 93:11080-11084
47. Brooks PC, Strömblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996, 85:683-693
48. Shioda T, Fenner MH, Isselbacher KJ: Experimental Animal Model of Hematogenous Cardiac Metastasis and Neoplastic Cardiac Tamponade. J Surg Oncol 1997, 64:122-126
49. Hanna N, Fidler IJ: Role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst 1980, 65:801-809
50. Gorelik E, Wiltrout RH, Okumura K, Habu S, Herberman RB: Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int J Cancer 1982, 30:107-112
51. Cohen SA, Tzung S-P, Doerr RJ, Goldrosen MH: Role of asialo-GM1 positive liver cells from athymic nude or polyinosinic-polycystidylic acid-treated mice in suppressing colon-derived experimental hepatic metastasis. Cancer Res 1990, 50:1834-1840
52. Weiss L, Nannmark U, Johansson BR, Bagge U: Lethal deformation of cancer cells in the microcirculation: a potential rate regulator of hematogenous metastasis. Int J Cancer 1992, 50:103-107
53. Schiavi SC, Wellington CL, Shyu AB, Chen CY, Greenberg ME, Belasco JG: Multiple elements in the c-fos protein-coding region facilitate mRNA deadenylation and decay by a mechanism coupled to translation. J Biol Chem 1994, 269:3441-3448
54. Campbell CE, Flenniken AM, Skup D, Williams BRG: Identification of a serum- and phorbol ester-responsive element in the murine tissue inhibitor of metalloproteinase gene. J Biol Chem 1991, 266:7199-7206
55. Nerlov C, Rorth P, Blasi F, Johnsen M: Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 1991, 6:1583-1592
56. Dellian M, Witwer BP, Salehi HA, Yuan F, Jain RK: Quantitation and physiological characterization of angiogenic vessels in mice. Am J Pathol 1996, 149:59-71
57. Roberts WG, Palade GE: Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995, 108: 2369-2379
58. Siemeister G, Schnurr B, Mohrs K, Schachtele C, Marme D, Martiny-Baron G: Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli. Biochem Biophys Res Commun 1996, 222:249-255
59. Hearing VJ, Law LW, Corti A, Appella E, Blasi F: Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. Cancer Res 1988, 48:1270-1278